ETNB
|
89bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
DTIL
|
Precision BioSciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
DBTX
|
Decibel Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
CTMX
|
CytomX Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
CRIS
|
Curis, Inc.
|
0.01%
|
US
|
NASDAQ
|
CLSD
|
Clearside Biomedical, Inc.
|
0.01%
|
US
|
NASDAQ
|
CGEN
|
Compugen
|
0.01%
|
IL
|
TA
|
CADL
|
Candel Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
BOLT
|
Bolt Biotherapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
BDTX
|
Black Diamond Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
BCAB
|
BioAtla, Inc.
|
0.01%
|
US
|
NASDAQ
|
AUTL
|
Autolus Therapeutics plc
|
0.01%
|
US
|
NASDAQ
|
ATHA
|
Athira Pharma, Inc.
|
0.01%
|
US
|
NASDAQ
|
AMTI
|
Applied Molecular Transport Inc.
|
0.01%
|
US
|
NASDAQ
|
ALLK
|
Allakos Inc.
|
0.01%
|
US
|
NASDAQ
|
AKUS
|
Akouos, Inc.
|
0.01%
|
US
|
NASDAQ
|
AKBA
|
Akebia Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
ADVM
|
Adverum Biotechnologies, Inc.
|
0.01%
|
US
|
NASDAQ
|
ACHL
|
Achilles Therapeutics plc
|
0.01%
|
US
|
NASDAQ
|
VOR
|
Vor Biopharma Inc.
|
0.01%
|
US
|
NASDAQ
|